Skip to main content

Incontinence: Medical Equipment

Volume 475: debated on Thursday 15 May 2008

To ask the Secretary of State for Health (1) what timetable he has set for publication of the outcomes of the review of Part IX of the Drug Tariff for the provision of stoma and incontinence appliances and related services to primary care; and if he will make a statement; (205631)

(2) what consideration has been given to section 1.2.5.3 of the National Institute for Clinical Excellence's clinical guideline 40, on urinary incontinence, in the review into Part IX of the Drug Tariff for the provision of stoma and incontinence appliances and related services to primary care; and if he will make a statement.

The review is ongoing. A further consultation will be published shortly—together with an Impact Assessment and Equality Impact Assessment—and will be open for 12 weeks.

Section 1.2.5.3 of the National Institute for Health and Clinical Excellence's clinical guideline number 40 on urinary incontinence states that intermittent urinary (IU) catheterisation should be used for women with urinary retention who can be taught to self-catheterise or who have a carer to perform the technique.

The review of arrangements under Part IX of the Drug Tariff for the provision of stoma and incontinence appliances and related services in primary care is looking at the reimbursement for IU catheters. However, decisions relating to what item shall be prescribed will continue to be a matter for the prescriber to decide in consultation with the patient, having taken the guidelines fully into account.